Prognostic Value of the t(14;18)(q32;q21) in Patients With Diffuse Large B-Cell Lymphoma

REFERENCES

• Jaffe, E.; Harris, N.; Stein, H.; Vardiman, J. Pathology and genetics of tumors of the hematopoietic and lymphoid tissues. WHO Classification of Tumors. Lyon-France: IARC Press, 2001.
   Google Scholar
• Mokhtar, N.; Khalid, H. Diffuse large B-cell lymphoma. In Lymphoma Text Book, 1st edition. Cairo: National Cancer Institute, 2002, 123.
   Google Scholar
• Vaandrager, J.W.; Schuuring, E.; Raap, T.; Philippo, K.; Kleiverda, K.; Kluin, P. Interphase FISH detection of BCL-2 rearrangement in follicular lymphoma using breakpoint-flanking probes genes chromosomes. Cancer 2000, 27, 85–94.
   Web of Science ®Google Scholar
• Biagi, J.; Seymour, J. Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood 2002, 99, 4265–4275.
   PubMed Web of Science ®Google Scholar
• Jacobson, J.O.; Wilkes, B.M.; Kwaiatkowski, D.J.; Medeiros, L.J.; Aisenberg, A.C.; Harris, N.L. bcl-2 rearrangements in de novo diffuse large cell lymphoma. Association with distinctive clinical features. Cancer (Phila.) 1993, 72, 231–236.
   PubMed Web of Science ®Google Scholar
• Tang, S.C.; Visser, L.; Hepperle, B.; Hanson, J.; Poppema, S. Clinical significance of bcl-2-MBR gene rearrangement and protein expression in diffuse large-cell non-Hodgkin's lymphoma: an analysis of 83 cases. J Clin Oncol 1994, 12, 149–154.
   PubMed Web of Science ®Google Scholar
• Kramer, M.H.; Hermans, J.; Wijburg, E.; Filippo, K.; Geelen, E.; van Krieken, J.H.; de Jong, D.; Maartense, E.; Schuuring, E.; Kluin, P.M. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma. Blood 1998, 92, 3152–3162.
   PubMed Web of Science ®Google Scholar
• Martinka, M.; Comeau, T.; Foyle, A.; Anderson, D.; Greer, W. Prognostic significance of t (14;18) and bcl-2 gene expression in follicular small cleaved cell lymphoma and diffuse large cell lymphoma. Clin Investig Med 1997, 20, 364–370.
   PubMed Web of Science ®Google Scholar
• Barrans, S.L.; Evans, P.A.S.; O'Connor, S.J.M.; Owen, R.G.; Morgan, G.J.; Jack, A.S. The detection of t(14;18) in archival lymph nodes. Development of a fluorescence in situ hybridization (FISH)-based method and evaluation by comparison with polymerase chain reaction. Am SocInvestig Pathol Assoc Mol Pathol 2003, 5(3), 168–175.
   Google Scholar
• van Dongen, J.J.; Langerak, A.W.; Bruggemann, M. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations. Report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 2003, 17(12), 2257–2317.
   PubMed Web of Science ®Google Scholar
• Barrans, S.L.; Evans, P.A.S.; O'Connor, S.J.M. The t (14;18) is associated with germinal center–derived diffuse large B- cell lymphoma and is a strong predictor of outcome. Am Assoc Cancer Res 2003, 9, 2133–2139.
   Google Scholar
• Haung, J.Z.; Sanger, W.G.; Greiner, T.C.; Staudt, L.M.; Weisenburger, D.D.; Pickering, D.L.; Lynch, J.C.; Armitage, J.O.; Warnke, R.A.; Alizadeh, A.A.; Lossos, I.S.; Levy, R.; Chan, W.C. The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. Blood 2002, 99, 2285–2290.
   PubMed Web of Science ®Google Scholar
• Fang, J.M.; Finn, W.G.; Hussong, J.W.; Goolsby, C.L.; Cubbon, A.R.; Variakojis, D. CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma. Mod Pathol 1999, 12(3), 295–300.
   PubMed Web of Science ®Google Scholar
• Le Gouill, S.; Talmant, P.; Touzeau, C.; Moreau, A.; Garand, R.; Juge-Morineau, N.; Gaillard, F.; Gastinne, T.; Milpied, N.; Moreau, P.; Harousseau, J.L.; Avet-Loiseau, H. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18)and 8q24/c-MYC rearrangement. Hematologica 2007, 92(10), 1335–1342.
   PubMed Web of Science ®Google Scholar
• Shipp, M.; Harrington, D. A predictive model for aggressive NHL. The international NHL prognostic factors project. N Engl J Med 1993, 329, 987–994.
   PubMed Web of Science ®Google Scholar
• Foussard, C.; Desablens, B.; Senseble, L. Is the international prognostic for aggressive lymphoma useful for low grade lymphoma patients? Applicability to stage III, IV patients. Ann Oncol 1997, 8, 49–55.
   PubMed Web of Science ®Google Scholar
• Hirose, Y.; Masaki, Y.; Karasawa, H.; Shimoyama, K.; Fukushima, T.; Kawabata, H.; Ogawa, N.; Wano, Y.; Ozaki, M. Incidence of diffuse large B-cell lymphoma of germinal center B-cell origin in whole diffuse large B-cell lymphoma: tissue fluorescence in situ hybridization using t(14;18) compared with immunohistochemistry. Int J Hematol 2005, 81, 48–57.
   PubMed Web of Science ®Google Scholar
• Barrans, S.L.; Carter, I.; Owen, R.G.; Daves, F.F.; Patmore, R.D.; Haynes, A.P.; Morgan, G.J.; Jack, A.S. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood 2002, 99(4), 1136–1143.
   PubMed Web of Science ®Google Scholar
• Wilson, K.S.; Sehn, L.H.; Berry, B.; Chhanabhai, M.M.; Fitzgerald, C.A.; Gill, K.K.; Klasa, R.; Skinnider, B.; Sutherland, J.; Connors, J.M.; Gascoyne, R.D. CHOP-R therapy overcomes the adverse prognostic influence of BCL-2expression in diffuse large B-cell lymphoma. Leuk lymphoma 2007, 48(6), 1102–1109.
   PubMed Web of Science ®Google Scholar
• Borovecki, A.; Koraæ, B.; Nola, M.; Ivankoviæ, D.; Jaksiæ, B.; Dominis, M. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3. Croat Med J 2008, 49(5), 625–635.
   PubMed Web of Science ®Google Scholar